Literature DB >> 17257657

Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study.

Torben Bjerregaard Larsen1, Henrik Toft Sørensen, Mette Gislum, Søren Paaske Johnsen.   

Abstract

BACKGROUND: Smoking and obesity are associated with adverse pregnancy outcomes. The aim of the present study was to examine the association between smoking, obesity (BMI>30), and risk for venous thromboembolism (VTE) during pregnancy and the puerperium.
MATERIALS AND METHODS: In a population-based case-control study nested within a Danish cohort of 71,729 women, we identified 129 cases with VTE in pregnancy or the puerperium, and 258 pregnant non-VTE controls. We obtained data from medical records regarding current smoking status, BMI, and other covariates, and computed the odds ratios (OR) for VTE as a measure of relative risk.
RESULTS: Smoking and obesity were associated with increased risk of VTE during pregnancy and the puerperium (adjusted OR 2.7 (95% CI: 1.5, 4.9) and 5.3 (95% CI: 2.1, 13.5), respectively). Obesity appeared to be associated with a higher risk of pulmonary embolism (adjusted OR: 14.9 (95% CI: 3.0, 74.8) than of deep venous thrombosis (adjusted OR: 4.4, 95% CI: 1.6, 11.9).
CONCLUSION: Smoking and obesity are risk factors for VTE in pregnancy and the puerperium.

Entities:  

Mesh:

Year:  2007        PMID: 17257657     DOI: 10.1016/j.thromres.2006.12.003

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  37 in total

1.  Embolectomy for massive pulmonary embolism after cesarean delivery.

Authors:  Ki Hoon Ahn; Soon-Cheol Hong
Journal:  CMAJ       Date:  2015-09-21       Impact factor: 8.262

2.  Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England.

Authors:  Alyshah Abdul Sultan; Matthew J Grainge; Joe West; Kate M Fleming; Catherine Nelson-Piercy; Laila J Tata
Journal:  Blood       Date:  2014-08-25       Impact factor: 22.113

Review 3.  Obesity in pregnancy: risks and management.

Authors:  Kate J Fitzsimons; Jo Modder; Ian A Greer
Journal:  Obstet Med       Date:  2009-05-22

4.  Developing a model for predicting venous thromboembolism in obese pregnant women in a national study.

Authors:  Julia Ellis-Kahana; Andrew D Sparks; Alexis C Gimovsky; Andra H James; Homa K Ahmadzia
Journal:  Thromb Res       Date:  2020-04-23       Impact factor: 3.944

Review 5.  Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child.

Authors:  Patrick M Catalano; Kartik Shankar
Journal:  BMJ       Date:  2017-02-08

6.  Associations of maternal obesity and smoking status with perinatal outcomes.

Authors:  Julie K Phillips; Joan M Skelly; Sarah E King; Ira M Bernstein; Stephen T Higgins
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-14

7.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.

Authors:  Shannon M Bates; Anita Rajasekhar; Saskia Middeldorp; Claire McLintock; Marc A Rodger; Andra H James; Sara R Vazquez; Ian A Greer; John J Riva; Meha Bhatt; Nicole Schwab; Danielle Barrett; Andrea LaHaye; Bram Rochwerg
Journal:  Blood Adv       Date:  2018-11-27

8.  Pregnancy-related deaths due to pulmonary embolism: findings from two state-based mortality reviews.

Authors:  Peter S Heyl; William M Sappenfield; Deborah Burch; Leticia E Hernandez; Victoria M Kavanaugh; Washington C Hill
Journal:  Matern Child Health J       Date:  2013-09

Review 9.  Pulmonary embolism in pregnancy.

Authors:  E Conti; L Zezza; E Ralli; C Comito; L Sada; J Passerini; D Caserta; S Rubattu; C Autore; M Moscarini; M Volpe
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

10.  Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium.

Authors:  Andrea Gerhardt; Rüdiger E Scharf; Ian A Greer; Rainer B Zotz
Journal:  Blood       Date:  2016-09-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.